eMedicine Specialties > Dermatology > Diseases of the Adnexa

Graham-Little-Piccardi-Lasseur Syndrome: Follow-up

Author: Scott Richard Albert Walsh, MD, PhD, Assistant Professor, Program Director, Department of Dermatology, University of Toronto, Sunnybrook Health Sciences Centre
Coauthor(s): Patricia T Ting, MSc, MD, Dermatology Resident, Division of Dermatology and Cutaneous Sciences, Department of Medicine, University of Alberta; Neil Shear, MD, Professor and Chief of Dermatology, Professor of Medicine, Pediatrics and Pharmacology, University of Toronto Faculty of Medicine; Head of Dermatology, Sunnybrook Women's College Health Sciences Center and Women's College Hospital, Canada
Contributor Information and Disclosures

Updated: Oct 13, 2009

Follow-up

Further Outpatient Care

  • Regular follow-up is recommended to assess the course of Graham-Little-Piccardi-Lasseur syndrome (GLPLS) and the effectiveness of prescribed treatments. Ask patients about any adverse effects to medications and manage accordingly.
  • Conduct appropriate laboratory studies as indicated with the use of systemic medications (ie, cyclosporine, thalidomide).
  • Take necessary steps to prevent permanent cicatricial alopecia.

Prognosis

  • Cicatricial scalp alopecia has a poor prognosis. This type of hair loss is permanent.
  • Noncicatricial alopecia of the axilla and groin often spontaneously resolves.
  • Follicular lichen planus eruption on the body usually responds well to treatment; however, recurrence is not uncommon.

Patient Education

  • Educate Graham-Little-Piccardi-Lasseur syndrome (GLPLS) patients on the psychosocial aspects of progressive cicatricial alopecia.
  • If indicated, discuss options and sources for cosmetic hairpieces to disguise end-stage scarring scalp alopecia.

Miscellaneous

Medicolegal Pitfalls

  • Failure to perform a biopsy on scalp lesions to confirm the scarring nature of the condition
  • Failure to offer medical intervention in an attempt to prevent further spread of scarring and irreversible alopecia
  • Failure to provide a clear discussion of the risk-to-benefit ratio of treatment options for this condition
 


More on Graham-Little-Piccardi-Lasseur Syndrome

Overview: Graham-Little-Piccardi-Lasseur Syndrome
Differential Diagnoses & Workup: Graham-Little-Piccardi-Lasseur Syndrome
Treatment & Medication: Graham-Little-Piccardi-Lasseur Syndrome
Follow-up: Graham-Little-Piccardi-Lasseur Syndrome
Multimedia: Graham-Little-Piccardi-Lasseur Syndrome
References
[ CLOSE WINDOW ]

References

  1. Graham-Little EG. Folliculitis decalvans et atrophicans. Br J Dermatol. 1915;27:183-5.

  2. Viglizzo G, Verrini A, Rongioletti F. Familial Lassueur-Graham-Little-Piccardi syndrome. Dermatology. 2004;208(2):142-4. [Medline].

  3. Ghislain PD, Van Eeckhout P, Ghislain E. Lassueur-Graham Little-Piccardi syndrome: a 20-year follow-up. Dermatology. 2003;206(4):391-2. [Medline].

  4. Bardazzi F, Landi C, Orlandi C, Neri I, Varotti C. Graham Little-Piccardi-Lasseur syndrome following HBV vaccination. Acta Derm Venereol. Jan 1999;79(1):93. [Medline].

  5. Rodriguez-Bayona B, Ruchaud S, Rodriguez C, et al. Autoantibodies against the chromosomal passenger protein INCENP found in a patient with Graham Little-Piccardi-Lassueur syndrome. J Autoimmune Dis. Jan 12 2007;4:1. [Medline].

  6. Rebora A, Rongioletti F, Drago F, Parodi. Lichen planus as a side effect of HBV vaccination. Dermatology. 1999;198(1):1-2. [Medline].

  7. Vega Gutierrez J, Miranda-Romero A, Perez Milan F, Martinez Garcia G. Graham Little-Piccardi-Lassueur syndrome associated with androgen insensitivity syndrome (testicular feminization). J Eur Acad Dermatol Venereol. Jul 2004;18(4):463-6. [Medline].

  8. Mobini N, Tam S, Kamino H. Possible role of the bulge region in the pathogenesis of inflammatory scarring alopecia: lichen planopilaris as the prototype. J Cutan Pathol. Nov 2005;32(10):675-9. [Medline].

  9. Moretti S, Amato L, Massi D, Bianchi B, Gallerani I, Fabbri P. Evaluation of inflammatory infiltrate and fibrogenic cytokines in pseudopelade of Brocq suggests the involvement of T-helper 2 and 3 cytokines. Br J Dermatol. Jul 2004;151(1):84-90. [Medline].

  10. Horn RT Jr, Goette DK, Odom RB, Olson EG, Guill MA. Immunofluorescent findings and clinical overlap in two cases of follicular lichen planus. J Am Acad Dermatol. Aug 1982;7(2):203-7. [Medline].

  11. Bottoni U, Innocenzi D, Carlesimo M. Treatment of Piccardi-Lassueur-Graham Little syndrome with cyclosporin A. Eur J Dermatol. 1995;5:216-9.

  12. Mirmirani P, Willey A, Price VH. Short course of oral cyclosporine in lichen planopilaris. J Am Acad Dermatol. Oct 2003;49(4):667-71. [Medline].

  13. Boyd AS, King LE Jr. Thalidomide-induced remission of lichen planopilaris. J Am Acad Dermatol. Dec 2002;47(6):967-8. [Medline].

  14. George SJ, Hsu S. Lichen planopilaris treated with thalidomide. J Am Acad Dermatol. Dec 2001;45(6):965-6. [Medline].

  15. Jouanique C, Reygagne P, Bachelez H, Dubertret L. Thalidomide is ineffective in the treatment of lichen planopilaris. J Am Acad Dermatol. Sep 2004;51(3):480-1. [Medline].

  16. Büyük AY, Kavala M. Oral metronidazole treatment of lichen planus. J Am Acad Dermatol. Aug 2000;43(2 Pt 1):260-2. [Medline].

  17. Amato L, Massi D, Berti S, Moretti S, Fabbri P. A multiparametric approach is essential to define different clinicopathological entities within pseudopelade of Brocq. Br J Dermatol. Mar 2002;146(3):532-3. [Medline].

  18. Bianchi L, Paro Vidolin A, Piemonte P, Carboni I, Chimenti S. Graham Little-Piccardi-Lassueur syndrome: effective treatment with cyclosporin A. Clin Exp Dermatol. Sep 2001;26(6):518-20. [Medline].

  19. Chieregato C, Zini A, Barba A, Magnanini M, Rosina P. Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol. May 2003;42(5):342-5. [Medline].

  20. Mirmirani P, Willey A, Headington JT, Stenn K, McCalmont TH, Price VH. Primary cicatricial alopecia: histopathologic findings do not distinguish clinical variants. J Am Acad Dermatol. Apr 2005;52(4):637-43. [Medline].

  21. Poblet E, Jimenez F, Pascual A, Pique E. Frontal fibrosing alopecia versus lichen planopilaris: a clinicopathological study. Int J Dermatol. Apr 2006;45(4):375-80. [Medline].

  22. Somani N, Bergfeld WF. Cicatricial alopecia: classification and histopathology. Dermatol Ther. Jul-Aug 2008;21(4):221-37. [Medline].

  23. Waldorf DS. Lichen planopilaris. Histopathologic study of disease. Progression to scarring alopedia. Arch Dermatol. Jun 1966;93(6):684-91. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

Graham-Little-Piccardi-Lasseur syndrome, GLPLS, Graham-Little-Feldman syndrome, Lassueur-Graham-Little-Piccardi syndrome, Piccardi-Lassueur-Graham-Little syndrome, Graham-Little-Piccardi-Lassueur syndrome, follicular lichen planus, LP, lichen spinulosus et folliculitis decalvans, lichen planopilaris, alopecia, cheratosi spinulosa, keratotic spinulosa, lichenoid dermatosis, hair loss, GLPL syndrome

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Scott Richard Albert Walsh, MD, PhD, Assistant Professor, Program Director, Department of Dermatology, University of Toronto, Sunnybrook Health Sciences Centre
Scott Richard Albert Walsh, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Canadian Dermatology Association, International Society of Dermatology, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Coauthor(s)

Patricia T Ting, MSc, MD, Dermatology Resident, Division of Dermatology and Cutaneous Sciences, Department of Medicine, University of Alberta
Patricia T Ting, MSc, MD is a member of the following medical societies: Alberta Medical Association, Canadian Dermatology Association, and Canadian Medical Association
Disclosure: Nothing to disclose.

Neil Shear, MD, Professor and Chief of Dermatology, Professor of Medicine, Pediatrics and Pharmacology, University of Toronto Faculty of Medicine; Head of Dermatology, Sunnybrook Women's College Health Sciences Center and Women's College Hospital, Canada
Neil Shear, MD is a member of the following medical societies: American Academy of Dermatology, American Society for Clinical Pharmacology and Therapeutics, Canadian Dermatology Association, Canadian Medical Association, Ontario Medical Association, and Royal College of Physicians and Surgeons of Canada
Disclosure: Nothing to disclose.

Medical Editor

Franklin Flowers, MD, Chief, Division of Dermatology, Professor, Department of Medicine and Otolaryngology, University of Florida College of Medicine
Franklin Flowers, MD is a member of the following medical societies: American College of Mohs Micrographic Surgery and Cutaneous Oncology
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Managing Editor

Jeffrey J Miller, MD, Associate Professor of Dermatology, Penn State University College of Medicine; Staff Dermatologist, Penn State Milton S Hershey Medical Center
Jeffrey J Miller, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Association of Professors of Dermatology, North American Hair Research Society, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.